Literature DB >> 8524979

Contrasting effects of clonidine and diazepam on tests of working memory and planning.

J T Coull1, H C Middleton, T W Robbins, B J Sahakian.   

Abstract

The alpha 2 adrenoceptor has recently been implicated in working memory (WM), a function dependent on the integrity of the prefrontal cortex. Using a double-blind, placebo-controlled design, the present investigation examines the effects of two doses (1.5 micrograms/kg and 2.5 micrograms/kg) of the mixed alpha 1/alpha 2 adrenoceptor agonist clonidine (CLO) on performance of various computerised tests of WM and planning in healthy, young volunteers. These are compared to the effects produced by two doses (5 mg and 10 mg) of diazepam (DZP) on largely the same set of neuropsychological tests in a comparable set of subjects. Administration of CLO resulted in impulsivity of responding in a planning task, as well as differential dose-dependent effects on two analogous tests of spatial and visual WM. The nature of these effects were suggestive of mnemonic, rather than executive, dysfunction. Conversely, DZP produced specific deficits on tests of spatial WM and planning very similar to those seen following lesions to the frontal lobes. Therefore, these two sedative drugs produce doubly dissociable, dose-dependent effects on different aspects of cognitive function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8524979     DOI: 10.1007/bf02311179

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  31 in total

1.  Double dissociations of memory and executive functions in working memory tasks following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man.

Authors:  A M Owen; R G Morris; B J Sahakian; C E Polkey; T W Robbins
Journal:  Brain       Date:  1996-10       Impact factor: 13.501

2.  Planning and spatial working memory following frontal lobe lesions in man.

Authors:  A M Owen; J J Downes; B J Sahakian; C E Polkey; T W Robbins
Journal:  Neuropsychologia       Date:  1990       Impact factor: 3.139

3.  The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes.

Authors:  A F Arnsten; J X Cai; P S Goldman-Rakic
Journal:  J Neurosci       Date:  1988-11       Impact factor: 6.167

Review 4.  Central neuronal pathways and the process of anaesthesia.

Authors:  A Angel
Journal:  Br J Anaesth       Date:  1993-07       Impact factor: 9.166

5.  Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex.

Authors:  P S Goldman-Rakic; M S Lidow; D W Gallager
Journal:  J Neurosci       Date:  1990-07       Impact factor: 6.167

6.  Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha-2 adrenoceptors.

Authors:  V A Doze; B X Chen; M Maze
Journal:  Anesthesiology       Date:  1989-07       Impact factor: 7.892

7.  Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man.

Authors:  A M Owen; A C Roberts; C E Polkey; B J Sahakian; T W Robbins
Journal:  Neuropsychologia       Date:  1991       Impact factor: 3.139

8.  Fronto-striatal cognitive deficits at different stages of Parkinson's disease.

Authors:  A M Owen; M James; P N Leigh; B A Summers; C D Marsden; N P Quinn; K W Lange; T W Robbins
Journal:  Brain       Date:  1992-12       Impact factor: 13.501

9.  Sedative-hypnotics and human performance.

Authors:  L C Johnson; D A Chernik
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

10.  Selective impairment of paired associate learning after administration of a centrally-acting adrenergic agonist (clonidine).

Authors:  C D Frith; J Dowdy; I N Ferrier; T J Crow
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more
  28 in total

Review 1.  Memory assessment in studies of cognition-enhancing drugs for Alzheimer's disease.

Authors:  M Simard; R van Reekum
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

Review 2.  Neuroanatomical and neurochemical substrates of timing.

Authors:  Jennifer T Coull; Ruey-Kuang Cheng; Warren H Meck
Journal:  Neuropsychopharmacology       Date:  2010-07-28       Impact factor: 7.853

3.  Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes.

Authors:  Miriam Z Mintzer; Roland R Griffiths
Journal:  Cogn Affect Behav Neurosci       Date:  2007-06       Impact factor: 3.282

4.  Desipramine attenuates working memory impairments induced by partial loss of catecholamines in the rat medial prefrontal cortex.

Authors:  S M Clinton; I L Sucharski; J M Finlay
Journal:  Psychopharmacology (Berl)       Date:  2005-11-24       Impact factor: 4.530

5.  D1- versus D2-receptor modulation of visuospatial working memory in humans.

Authors:  U Müller; D Y von Cramon; S Pollmann
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

Review 6.  Noradrenergic modulation of working memory and emotional memory in humans.

Authors:  Samuel R Chamberlain; Ulrich Müller; Andrew D Blackwell; Trevor W Robbins; Barbara J Sahakian
Journal:  Psychopharmacology (Berl)       Date:  2006-04-27       Impact factor: 4.530

7.  Successful treatment of severe disruptive disorder featuring symptoms of the Klüver-Bucy Syndrome following a massive right temporal-parietal hemorrhage.

Authors:  Luigi De Benedictis; Alexandre Dumais; Pierre Landry
Journal:  Neurol Sci       Date:  2012-01-04       Impact factor: 3.307

8.  Diazepam produces disinhibitory cognitive effects in male volunteers.

Authors:  J B Deakin; M R F Aitken; J H Dowson; T W Robbins; B J Sahakian
Journal:  Psychopharmacology (Berl)       Date:  2003-12-19       Impact factor: 4.530

9.  Lack of effects of guanfacine on executive and memory functions in healthy male volunteers.

Authors:  Ulrich Müller; Luke Clark; Minh L Lam; Rebecca M Moore; C Louise Murphy; Nicola K Richmond; Ranbir S Sandhu; Ingrid A Wilkins; David K Menon; Barbara J Sahakian; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

10.  The alpha(2) antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type.

Authors:  J T Coull; B J Sahakian; J R Hodges
Journal:  Psychopharmacology (Berl)       Date:  1996-02       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.